top of page
Cancer Vaccine Institute News
kkd616
May 27, 2021
Meet Kim P. - CVI Trial Participant
Kim was diagnosed with stage IIIC ovarian cancer on September 28, 2009. She had experienced some of the classic symptoms of ovarian...
Jamie C
May 27, 2021
Meet Jamie - Fierce advocate for ovarian cancer patients
By Jamie C. My cancer story begins in 2007, when I was a healthy, traveling, living life, family planning 34 year old. I had never been...
Kiran Dhillon
May 27, 2021
Meet Kim, a CVI Champion
Kim C. participated in one of our clinical trials in 2005. We are so grateful for Kim and all of our patient volunteers! Their...
Liliana Gutierrez
May 2, 2021
CVI research continues full steam ahead during the pandemic
What happens to cancer research in a pandemic? We know that cancer does not slow its roll in a pandemic so the CVI adapted quickly
Liliana Gutierrez
May 2, 2021
Alpha-TEA strikes down advanced breast cancer?
CVI’s Dr. William Gwin was interviewed by NBC 10 in Rhode Island about his Phase 1 clinical trial
Liliana Gutierrez
May 2, 2021
Cancer Vaccine Trial Challenges During the COVID Pandemic
Dr. Will Gwin and colleagues recently discussed the challenges cancer vaccine clinical trials faced due to the pandemic.
Liliana Gutierrez
May 2, 2021
Thank you Safeway and Albertsons
The UW Medicine Cancer Vaccine Institute and the Fred Hutch thank Safeway and Albertsons for their March check stand fundraiser!
Liliana Gutierrez
Apr 25, 2021
Safeway & Albertsons
Thank you Safeway and Albertsons for your incredible fundraising efforts on behalf of the UW Medicine Cancer Vaccine Institute!
Liliana Gutierrez
Apr 25, 2021
Talking Rain
Our team joyfully accepted a gift of $50,000 to support CVI breast cancer research during a virtual check presentation with Nina Morrison an
Liliana Gutierrez
Apr 25, 2021
Wings of Karen
The CVI is grateful to one of our longest and most generous donors—Wings of Karen. Kristi Blair established this foundation in honor of her
Liliana Gutierrez
Apr 25, 2021
Women Trailblazers at UW Medicine Highlight CVI's Dr. Nora Disis
CVI Director, Dr. Nora Disis was featured in a recent Women Trailblazers at UW Medicine virtual event which was moderated by Dr. Shaveta Vin
Liliana Gutierrez
Apr 25, 2021
Vaccine and Clinical Trials - 2020 in Review
The CVI is developing vaccines for breast, colon, ovarian, prostate, pancreatic, sarcoma, lung, and bladder cancers. While our early...
Liliana Gutierrez
Apr 25, 2021
CVI Team Highlight: Doreen Higgins
oreen has dedicated over 15 years to being a fierce advocate for our research participants.
Liliana Gutierrez
Apr 25, 2021
CVI Launches Patient Advisory Council
The Cancer Vaccine Institute has launched a Patient Advisory Council as part of our efforts to increase patient engagement and education.
Liliana Gutierrez
Mar 4, 2021
CVI Research Continues Full Steam Ahead in the Pandemic
We could not waiver on our mission to develop cancer vaccines and other immune therapies and must keep progressing our research.
Liliana Gutierrez
Aug 26, 2020
Novel breast cancer therapy candidate Alpha-TEA enters clinical study
We're excited to announce a new clinical trail for advanced stage HER2+ breast cancer, in partnership with Veana Therapeutics.
Liliana Gutierrez
Apr 16, 2020
Developing vaccines for cancer and COVID-19
Check out this American Cancer Society Theory Lab podcast featuring the CVI's fearless leader, Dr. Nora Disis.
Liliana Gutierrez
Sep 19, 2019
How I Became a Physician-Scientist
Dr. Nora Disis, CVI Director, discusses her career path as a physician-scientist with ASCO Connection
Liliana Gutierrez
Sep 17, 2019
The Importance of Clinical Trials
Dr. Disis discusses the importance of clinical trials with Seattle's KOMO 4 News. Read the more here.
Liliana Gutierrez
Jul 15, 2019
Personalized Cancer Vaccines in Clinical Trials
Personalized cancer vaccines in clinical trials article in The Scientist (July 2019)
Blog: Blog2
bottom of page